BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28434308)

  • 1. AA cardiomyopathy.
    Dasgupta NR; Cummings OW; Phillips CL; Benson MD
    Amyloid; 2017 Mar; 24(sup1):138-139. PubMed ID: 28434308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multisystemic amyloidosis in 2007].
    Grateau G; Valleix S; Callard P
    Rev Med Interne; 2007 May; 28(5):281-3. PubMed ID: 17291633
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new treatment of renal disease in AA amyloidosis...and not only that?].
    Pani A
    G Ital Nefrol; 2008; 25(1):12. PubMed ID: 18264913
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in the treatment of amyloidosis.
    Rajkumar SV; Gertz MA
    N Engl J Med; 2007 Jun; 356(23):2413-5. PubMed ID: 17554124
    [No Abstract]   [Full Text] [Related]  

  • 5. Eprodisate in AA amyloidosis.
    Manenti L; Tansinda P; Vaglio A
    N Engl J Med; 2007 Sep; 357(11):1153; author reply 1153-4. PubMed ID: 17855678
    [No Abstract]   [Full Text] [Related]  

  • 6. [New trends in the treatment of amyloidosis].
    Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R
    Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?
    Manenti L; Tansinda P; Vaglio A
    Expert Opin Pharmacother; 2008 Aug; 9(12):2175-80. PubMed ID: 18671471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amyloidosis in rheumatic diseases].
    Zdrojewski Z
    Ann Acad Med Stetin; 2010; 56 Suppl 1():7-15. PubMed ID: 21365934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CARDIAC AMYLOIDOSIS. DIAGNOSTICS AND TREATMENT OF AMYLOID CARDIOMYOPATHY. CASE REPORT].
    Nonka TG; Repin AN
    Klin Med (Mosk); 2015; 93(4):66-73. PubMed ID: 26155713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide.
    Philippakis AA; Falk RH
    Circulation; 2012 Apr; 125(14):1821-4. PubMed ID: 22492950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Restrictive cardiomyopathy in primary amyloidosis].
    Miasnikov AL; Riabykina GV; Sokolova RI; Gorbacheva ON; Attalaukhanova DM; Iavorskaia NV; Karpov IuA
    Kardiologiia; 1991 Jun; 31(6):110-2. PubMed ID: 1921120
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac amyloidosis. Therapeutic and diagnostic difficulties with reference to two different forms of the disease.
    Leinonen H; Pohjola-Sintonen S
    Acta Med Scand; 1986; 219(1):125-8. PubMed ID: 3953311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac amyloidosis. Comment on the case report by Brychta et al: Restrictive cardiomyopathy as a manifestation of primary amyloidosis].
    Gregor P
    Vnitr Lek; 2004 Jan; 50(1):6. PubMed ID: 15015221
    [No Abstract]   [Full Text] [Related]  

  • 14. The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
    Decker I; Goodman SA; Phillips SE; Lenihan DJ; Cornell RF
    Br J Haematol; 2017 May; 177(3):481-483. PubMed ID: 28295184
    [No Abstract]   [Full Text] [Related]  

  • 15. [The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology].
    Kuchynka P; Palecek T; Simek S; Lubanda JC; Elleder M; Spicka I; Jansa P; Linhart A
    Vnitr Lek; 2008 Oct; 54(10):1010-3. PubMed ID: 19009770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual Case of Cardiac Amyloidosis Preceded by a Twenty-year History of Dilated Cardiomyopathy and Heart Failure.
    Shimada S; Maekura S; Ino H; Matsuura M; Masunaga N; Matsumoto T; Hama J
    Intern Med; 2016; 55(9):1109-15. PubMed ID: 27150863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Marked efficacy of adalimumab for secondary gastrointestinal amyloidosis accompanied with ankylosing spondylitis].
    Abe T; Azuma N; Kono T; Hao H; Hirota S; Ogita C; Yokoyama Y; Furukawa T; Yoshikawa T; Hino T; Saito A; Nishioka A; Sekiguchi M; Kitano M; Tsunoda S; Matsui K; Sano H
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(6):473-9. PubMed ID: 27118335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
    Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
    Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin D and cardiac amyloidosis: development and a case illustration.
    Servonnet A; Bouvier F; Garcia Hejl C; Sanmartin N; Renard C
    Ann Biol Clin (Paris); 2016 Jun; 74(3):329-32. PubMed ID: 27237804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic approach to cardiac amyloidosis: A case report.
    Fernandes A; Caetano F; Almeida I; Paiva L; Gomes P; Mota P; Trigo J; Botelho A; Cachulo Mdo C; Alves J; Francisco L; Leitão Marques A
    Rev Port Cardiol; 2016 May; 35(5):305.e1-7. PubMed ID: 27118142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.